Detalhe da pesquisa
1.
Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity.
Immunity
; 56(8): 1876-1893.e8, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480848
2.
Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation.
Blood
; 143(16): 1656-1669, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295333
3.
IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling.
Blood
; 134(23): 2092-2106, 2019 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578204
4.
Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade.
Blood
; 132(16): 1675-1688, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154111
5.
TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma.
Blood
; 132(16): 1689-1694, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29986909
6.
TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.
Sci Immunol
; 9(94): eadg1094, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640253
7.
IL-6-mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation.
J Clin Invest
; 134(7)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557487
8.
Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology models.
Front Immunol
; 14: 1127896, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090730
9.
Oncogenic drivers dictate immune control of acute myeloid leukemia.
Nat Commun
; 14(1): 2155, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059710
10.
TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in mice.
J Clin Invest
; 133(4)2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512425
11.
Depletion of exhausted alloreactive T cells enables targeting of stem-like memory T cells to generate tumor-specific immunity.
Sci Immunol
; 7(76): eabo3420, 2022 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240285
12.
Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
Front Immunol
; 12: 651288, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33777050
13.
Peritransplant glucocorticoids redistribute donor T cells to the bone marrow and prevent relapse after haploidentical SCT.
JCI Insight
; 6(22)2021 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637399
14.
Immunotherapy of multiple myeloma.
J Clin Invest
; 130(4): 1565-1575, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32149732
15.
Bone marrow transplantation generates T cell-dependent control of myeloma in mice.
J Clin Invest
; 129(1): 106-121, 2019 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30300141
16.
Flt-3L Expansion of Recipient CD8α+ Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD.
Clin Cancer Res
; 24(7): 1604-1616, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29367429